At ATS 2026, Krunal Patel, MD, discussed early real-world data suggesting sotatercept may improve hemodynamics, RV remodeling, and functional outcomes in group 3 CLD-PH.
Krunal Patel, MD
Advertisement
Krunal Patel, MD, of Temple University Hospital.
Articles by Krunal Patel, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Long-Acting Growth Hormone Analogs: Beyond Convenience to Individualized Care
2
All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study
3
Real-World Registries vs Clinical Trials in Long-Acting Growth Hormone Therapy
4
The HCPFive: Top News for Healthcare Providers from the Week of 07/05
5